At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke
In Brief
A Phase 3 clinical trial evaluating Varenicline, Positively Smoke Free, and 2 other interventions for Smoking and HIV. Completed, enrolled 184 participants across 1 site.
Detailed Summary
The single greatest health behavior change that could improve cardiovascular morbidity and associated mortality is to assist people living with HIV/AIDS who smoke to quit. The investigators will use a factorial design to evaluate the most promising behavioral and pharmacologic treatments aimed at achieving maximal efficacy for smoking cessation among people living with HIV/AIDS who smoke. Results of this study will provide crucial, real world evidence of the best way for healthcare providers to help smokers living with HIV/AIDS quit smoking.